Literature DB >> 29410074

The relative composition of actin isoforms regulates cell surface biophysical features and cellular behaviors.

Xin Xie1, Muhammedin Deliorman2, Mohammad A Qasaimeh3, Piergiorgio Percipalle4.   

Abstract

BACKGROUND: Cell surface mechanics is able to physically and biomechanically affect cell shape and motility, vesicle trafficking and actin dynamics. The biophysical properties of cell surface are strongly influenced by cytoskeletal elements. In mammals, tissue-specific expression of six actin isoforms is thought to confer differential biomechanical properties. However, the relative contribution of actin isoforms to cell surface properties is not well understood. Here, we sought to investigate whether and how the composition of endogenous actin isoforms directly affects the biomechanical features of cell surface and cellular behavior.
METHODS: We used fibroblasts isolated from wild type (WT), heterozygous (HET) and from knockout (KO) mouse embryos where both β-actin alleles are not functional. We applied a combination of genome-wide analysis and biophysical methods such as RNA-seq and atomic force microscopy.
RESULTS: We found that endogenous β-actin levels are essential in controlling cell surface stiffness and pull-off force, which was not compensated by the up-regulation of other actin isoforms. The variations of surface biophysical features and actin contents were associated with distinct cell behaviors in 2D and 3D WT, HET and KO cell cultures. Since β-actin in WT cells and smooth muscle α-actin up-regulated in KO cells showed different organization patterns, our data support the differential localization and organization as a mechanism to regulate the biophysical properties of cell surface by actin isoforms.
CONCLUSIONS: We propose that variations in actin isoforms composition impact on the biophysical features of cell surface and cause the changes in cell behavior.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Actin isoforms; Cell behavior; Membrane properties; Membrane tension; Transcriptomics; β-actin

Mesh:

Substances:

Year:  2018        PMID: 29410074     DOI: 10.1016/j.bbagen.2018.01.021

Source DB:  PubMed          Journal:  Biochim Biophys Acta Gen Subj        ISSN: 0304-4165            Impact factor:   3.770


  6 in total

1.  Responses of Acinetobacter baumannii Bound and Loose Extracellular Polymeric Substances to Hyperosmotic Agents Combined with or without Tobramycin: An Atomic Force Microscopy Study.

Authors:  Muhammedin Deliorman; F Pinar Gordesli Duatepe; Emily K Davenport; Boel A Fransson; Douglas R Call; Haluk Beyenal; Nehal I Abu-Lail
Journal:  Langmuir       Date:  2019-06-24       Impact factor: 3.882

2.  Characterizing circulating tumor cells using affinity-based microfluidic capture and AFM-based biomechanics.

Authors:  Muhammedin Deliorman; Ayoub Glia; Mohammad A Qasaimeh
Journal:  STAR Protoc       Date:  2022-05-27

3.  Elevated transforming growth factor β signaling activation in β-actin-knockout mouse embryonic fibroblasts enhances myofibroblast features.

Authors:  Xin Xie; Piergiorgio Percipalle
Journal:  J Cell Physiol       Date:  2018-05-31       Impact factor: 6.384

4.  β-actin regulates a heterochromatin landscape essential for optimal induction of neuronal programs during direct reprograming.

Authors:  Xin Xie; Robertas Jankauskas; Aslam M A Mazari; Nizar Drou; Piergiorgio Percipalle
Journal:  PLoS Genet       Date:  2018-12-17       Impact factor: 5.917

5.  Switching in the expression pattern of actin isoforms marks the onset of contractility and distinct mechanodynamic behavior during cardiomyocyte differentiation.

Authors:  Ricardo H Pires; Tung H Dau; Emmanuel Manu; Nithya Shree; Oliver Otto
Journal:  Physiol Rep       Date:  2022-02

Review 6.  Emerging roles of cytoskeletal proteins in regulating gene expression and genome organization during differentiation.

Authors:  Xin Xie; S Raza Mahmood; Tamara Gjorgjieva; Piergiorgio Percipalle
Journal:  Nucleus       Date:  2020-12       Impact factor: 4.197

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.